Drug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence
Abstract Since the 2019 novel coronavirus disease (COVID-19) outbreak in 2019 and the pandemic continues for more than one year, a vast amount of drug research has been conducted and few of them got FDA approval. Our objective is to prioritize repurposable drugs using a pipeline that systematically...
Enregistré dans:
Auteurs principaux: | Kanglin Hsieh, Yinyin Wang, Luyao Chen, Zhongming Zhao, Sean Savitz, Xiaoqian Jiang, Jing Tang, Yejin Kim |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/62b2501ae06e46a290cae495d7afa94f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
A method for the rational selection of drug repurposing candidates from multimodal knowledge harmonization
par: Bruce Schultz, et autres
Publié: (2021) -
Drug Therapeutic-Use Class Prediction and Repurposing Using Graph Convolutional Networks
par: Mapopa Chipofya, et autres
Publié: (2021) -
Drug repurposing for tooth regeneration: The promising premises
par: T C Divya, et autres
Publié: (2021) -
A Database of Drug Repurposing Clinical Trials in Oncology
par: Pan Pantziarka, et autres
Publié: (2021) -
Machine learning identifies candidates for drug repurposing in Alzheimer’s disease
par: Steve Rodriguez, et autres
Publié: (2021)